Around half of people with severe COVID-19 requiring intensive care unit (ICU) treatment will survive, but it is unclear how the immune response to SARS-CoV-2 differs between ICU patients that recover and those that do not. We conducted whole-blood immunophenotyping of COVID-19 patients upon admission to ICU and during their treatment and uncovered marked differences in their circulating immune cell subsets. At admission, patients who later succumbed to COVID-19 had significantly lower frequencies of all memory CD8+ T cell subsets, resulting in increased CD4-to-CD8 T cell and neutrophil-to-CD8 T cell ratios. ROC and Kaplan-Meier analyses demonstrated that both CD4-to-CD8 and neutrophil-to-CD8 ratios at admission were strong predictors of in-ICU mortality. Therefore, we propose the use of the CD4-to-CD8 T cell ratio as a marker for the early identification of those individuals likely to require enhanced monitoring and/or pro-active intervention in ICU.

Celica BIOMEDICAL Ljubljana Slovenia

Department of Anaesthesiology and Intensive Care Faculty of Medicine Masaryk University Brno Czech Republic

Department of Biology Faculty of Medicine Masaryk University Brno Czech Republic

Institute of Hematology and Blood Transfusion Prague Czech Republic

International Clinical Research Center St Anne's University Hospital Brno Brno Czech Republic

Zobrazit více v PubMed

Armstrong RA, Kane AD, Kursumovic E, Oglesby FC, Cook TM. Mortality in patients admitted to intensive care with COVID‐19: an updated systematic review and meta‐analysis of observational studies. Anaesthesia. 2021;76(4):537‐548. PubMed PMC

European Centre for Disease Prevention and Control . COVID‐19 surveillance report – Week 18. 2021:2021.

Saad‐Roy CM, Wagner CE, Baker RE, et al. Immune life history, vaccination, and the dynamics of SARS‐CoV‐2 over the next 5 years. Science. 2020;370(6518):811‐818. PubMed PMC

Mina MJ, Metcalf CJE, McDermott AB, Douek DC, Farrar J, Grenfell BT. A global lmmunological observatory to meet a time of pandemics. Elife. 2020;9:e58989. PubMed PMC

De Biasi S, Meschiari M, Gibellini L, et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID‐19 pneumonia. Nat Commun. 2020;11(1):3434. PubMed PMC

Chen Z, John Wherry E. T cell responses in patients with COVID‐19. Nat Rev Immunol. 2020;20(9):529‐536. PubMed PMC

Tavakolpour S, Rakhshandehroo T, Wei EX, Rashidian M. Lymphopenia during the COVID‐19 infection: what it shows and what can be learned. Immunol Lett. 2020;225:31‐32. PubMed PMC

Mann ER, Menon M, Knight SB, et al. Longitudinal immune profiling reveals key myeloid signatures associated with COVID‐19. Sci Immunol. 2020;5(51):eabd6197. PubMed PMC

Laing AG, Lorenc A, Del Molino Del Barrio I, et al. A dynamic COVID‐19 immune signature includes associations with poor prognosis. Nat Med. 2020;26(10):1623‐1635. PubMed

Sánchez‐Cerrillo I, Landete P, Aldave B, et al. COVID‐19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes. J Clin Invest. 2020;130(12):6290‐6300. PubMed PMC

Jeannet R, Daix T, Formento R, Feuillard J, François B. Severe COVID‐19 is associated with deep and sustained multifaceted cellular immunosuppression. Intensive Care Med. 2020;46(9):1769‐1771. PubMed PMC

Yan X, Li F, Wang X, et al. Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: a retrospective cross‐sectional study. J Med Virol. 2020;92(11):2573‐2581. PubMed PMC

Du RH, Liang LR, Yang CQ, et al. Predictors of mortality for patients with COVID‐19 pneumonia caused by SARS‐CoV‐2: a prospective cohort study. Eur Respir J. 2020;55(5):2000524. PubMed PMC

Zhang B, Zhou X, Zhu C, et al. Immune phenotyping based on the neutrophil‐to‐lymphocyte ratio and IgG level predicts disease severity and outcome for patients with COVID‐19. Front Mol Biosci. 2020;7(157):157. PubMed PMC

Carissimo G, Xu W, Kwok I, et al. Whole blood immunophenotyping uncovers immature neutrophil‐to‐VD2 T‐cell ratio as an early marker for severe COVID‐19. Nat Commun. 2020;11(1):5243. PubMed PMC

Schulte‐Schrepping J, Reusch N, Paclik D, et al. Severe COVID‐19 is marked by a dysregulated myeloid cell compartment. Cell. 2020;182(6):1419‐1440 e1423. PubMed PMC

McBride JA, Striker R. Imbalance in the game of T cells: what can the CD4/CD8 T‐cell ratio tell us about HIV and health? PLoS Pathog. 2017;13(11):e1006624. PubMed PMC

Li M, Yao D, Zeng X, et al. Age related human T cell subset evolution and senescence. Immun Ageing. 2019;16:24. PubMed PMC

Wikby A, Mansson IA, Johansson B, Strindhall J, Nilsson SE. The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20–100 years of age. Biogerontology. 2008;9(5):299‐308. PubMed

Liu J, Li S, Liu J, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS‐CoV‐2 infected patients. EBioMedicine. 2020;55:102763. PubMed PMC

Hortová‐Kohoutková M, Lázničková P, Bendíčková K, et al. Differences in monocyte subsets are associated with short‐term survival in patients with septic shock. J Cell Mol Med. 2020;24(21):12504‐12512. PubMed PMC

Coz Yataco AO, Simpson SQ. Coronavirus disease 2019 sepsis: a nudge toward antibiotic stewardship. Chest. 2020;158(5):1833‐1834. PubMed PMC

Benlyamani I, Venet F, Coudereau R, Gossez M, Monneret G. Monocyte HLA‐DR measurement by flow cytometry in COVID‐19 patients: an interim review. Cytometry A. 2020;97(12):1217‐1221. PubMed

Martin MD, Badovinac VP. Defining memory CD8 T cell. Front Immunol. 2018;9:2692. PubMed PMC

Martin‐Ruiz C, Hoffmann J, Shmeleva E, et al. CMV‐independent increase in CD27‐CD28+ CD8+ EMRA T cells is inversely related to mortality in octogenarians. NPJ Aging Mech Dis. 2020;6:3. PubMed PMC

Verma K, Ogonek J, Varanasi PR, et al. Human CD8+ CD57‐ TEMRA cells: too young to be called "old". PLoS One. 2017;12(5):e0177405. PubMed PMC

Parish ST, Wu JE, Effros RB. Sustained CD28 expression delays multiple features of replicative senescence in human CD8 T lymphocytes. J Clin Immunol. 2010;30(6):798‐805. PubMed PMC

Hamann D, Baars PA, Rep MH, et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med. 1997;186(9):1407‐1418. PubMed PMC

Pallotto C, Suardi LR, Esperti S, et al. Increased CD4/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID‐19): a retrospective multicentre study. Infect Dis (Lond). 2020;52(9):675‐677. PubMed

Liao D, Zhou F, Luo L, et al. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID‐19: a retrospective cohort study. Lancet Haematol. 2020;7(9):e671‐e678. PubMed PMC

Wang F, Hou H, Yao Y, et al. Systemically comparing host immunity between survived and deceased COVID‐19 patients. Cell Mol Immunol. 2020;17(8):875‐877. PubMed PMC

Adriaensen W, Derhovanessian E, Vaes B, et al. CD4:8 ratio >5 is associated with a dominant naive T‐cell phenotype and impaired physical functioning in CMV‐seropositive very elderly people: results from the BELFRAIL study. J Gerontol A Biol Sci Med Sci. 2015;70(2):143‐154. PubMed

Diao B, Wang C, Tan Y, et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID‐19). Front Immunol. 2020;11:827. PubMed PMC

Zhang H, Wu T. CD4+T, CD8+T counts and severe COVID‐19: a meta‐analysis. J Infect. 2020;81(3):e82‐e84. PubMed PMC

European Centre for Disease Prevention and Control . COVID‐19 surveillance report – Week 18. 2020:2020.

Persisting IL-18 levels after COVID-19 correlate with markers of cardiovascular inflammation reflecting potential risk of CVDs development

Hepcidin and ferritin levels as markers of immune cell activation during septic shock, severe COVID-19 and sterile inflammation

Prognostic value of soluble endoglin in patients with septic shock and severe COVID-19